Atrial fibrillation in hospitalized patients with end-stage liver disease: temporal trends in prevalence and outcomes.
Hedong HanYingyi QinYamei YuXin WeiHonglei GuoYiming RuanYang CaoJia HePublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
The prevalence of AF in hospitalized ESLD patients has continued to increase from 2003 through 2014. AF is associated with poor prognosis and higher health resource utilization. Innovative anticoagulation strategies through improved collaboration between cardiologists and hepatologists are required for better management of hospitalized ESLD patients comorbid with AF.
Keyphrases
- atrial fibrillation
- poor prognosis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- healthcare
- risk factors
- peritoneal dialysis
- long non coding rna
- public health
- type diabetes
- oral anticoagulants
- risk assessment
- patient reported outcomes
- left atrial
- venous thromboembolism
- climate change
- insulin resistance
- left ventricular
- health information
- human health
- patient reported